SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-12-004450
Filing Date
2012-08-09
Accepted
2012-08-09 17:26:18
Documents
13
Period of Report
2012-07-01

Document Format Files

Seq Description Document Type Size
1 PFIZER INC. 10-Q a50368790.htm 10-Q 3759924
2 EXHIBIT 12 a50368790ex12.htm EX-12 95717
3 EXHIBIT 15 a50368790ex15.htm EX-15 9500
4 EXHIBIT 31.1 a50368790ex31_1.htm EX-31.1 14557
5 EXHIBIT 31.2 a50368790ex31_2.htm EX-31.2 14562
6 EXHIBIT 32.1 a50368790ex32_1.htm EX-32.1 4418
7 EXHIBIT 32.2 a50368790ex32_2.htm EX-32.2 4567
  Complete submission text file 0001157523-12-004450.txt   20695650

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pfe-20120701.xml EX-101.INS 4200148
9 XBRL TAXONOMY EXTENSION SCHEMA pfe-20120701.xsd EX-101.SCH 118385
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pfe-20120701_cal.xml EX-101.CAL 147429
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20120701_lab.xml EX-101.LAB 763100
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20120701_pre.xml EX-101.PRE 615314
13 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT pfe-20120701_def.xml EX-101.DEF 529551
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 121021666
SIC: 2834 Pharmaceutical Preparations